IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39

Nature Immunology

Volumn 14, Issue 10, 2013, Pages 1054-1063

  Mascanfroni, Ivan D ^a   Yeste, Ada ^a   Vieira, Silvio M ^a   Burns, Evan J ^a   Patel, Bonny ^a   Sloma, Ido ^b   Wu, Yan ^a   Mayo, Lior ^a   Ben Hamo, Rotem ^b   Efroni, Sol ^b   Kuchroo, Vijay K ^a   Robson, Simon C ^a   Quintana, Francisco J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD39 ANTIGEN; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 27;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; DENDRITIC CELL; MOUSE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ANIMALS; ANTIBODIES; ANTIGEN PRESENTATION; ANTIGENS, CD; APYRASE; AUTOANTIBODIES; AUTOIMMUNITY; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNE TOLERANCE; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; MYELIN SHEATH; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION, GENETIC;

EID: 84886728752     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2695     Document Type: Article

References (50)

1. Nylander, A. & Hafler, D.A. Multiple sclerosis. J. Clin. Invest. 122, 1180-1188 (2012
2. Pierson, E., Simmons, S.B., Castelli, L. & Goverman, J.M. Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol. Rev. 248, 205-215 (2012
3. Bailey, S.L., Schreiner, B., Mcmahon, E.J. & Miller, S.D. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE. Nat. Immunol. 8, 172-180 (2007
4. Yogev, N. et al. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor+ regulatory T cells. Immunity 37, 264-275 (2012
5. Comabella, M., Montalban, X., Münz, C. & Lünemann, J.D. Targeting dendritic cells to treat multiple sclerosis. Nat. Rev. Nephrol. 6, 499-507 (2010
6. Greter, M. et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11, 328-334 (2005
7. McMahon, E.J., Bailey, S.L., Castenada, C.V., Waldner, H. & Miller, S.D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11, 335-339 (2005
8. Kastelein, R.A., Hunter, C.A. & Cua, D.J. Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25, 221-242 (2007
9. Molle, C., Goldman, M. & Goriely, S. Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process. J. Immunol. 184, 1784-1792 (2010
10. Mitsdoerffer, M. & Kuchroo, V. New pieces in the puzzle: How does interferon-β really work in multiple sclerosis? Ann. Neurol. 65, 487-488 (2009
11. Hunter, C.A. & Kastelein, R. Interleukin-27: Balancing protective and pathological immunity. Immunity 37, 960-969 (2012
12. Fitzgerald, D.C. et al. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 179, 3268-3275 (2007
13. Batten, M. et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929-936 (2006
14. Awasthi, A. et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8, 1380-1389 (2007
15. Fitzgerald, D.C. et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8, 1372-1379 (2007
16. Stumhofer, J.S. et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7, 937-945 (2006
17. Stumhofer, J.S. et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363-1371 (2007
18. Wang, S., Miyazaki, Y., Shinozaki, Y. & Yoshida, H. Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency. J. Immunol. 179, 6421-6428 (2007
19. Karakhanova, S., Bedke, T., Enk, A.H. & Mahnke, K. IL-27 renders DC immunosuppressive by induction of B7-H1. J. Leukoc. Biol. 89, 837-845 (2011
20. Matta, B.M., Raimondi, G., Rosborough, B.R., Sumpter, T.L. & Thomson, A.W. IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells. J. Immunol. 188, 5227-5237 (2012
21. Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C. & Amigorena, S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20, 621-667 (2002
22. Jung, S. et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17, 211-220 (2002
23. Ma, A. & Malynn, B.A. A20: Linking a complex regulator of ubiquitylation to immunity and human disease. Nat. Rev. Immunol. 12, 774-785 (2012
24. Weber, M. et al. Inference of dynamical gene-regulatory networks based on time-resolved multi-stimuli multi-experiment data applying NetGenerator V2.0. BMC Syst. Biol. 7, 1 (2013
25. Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265 (2007
26. Gandhi, R. et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3+ regulatory T cells. Nat. Immunol. 11, 846-853 (2010
27. Chalmin, F. et al. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. Immunity 36, 362-373 (2012
28. Eltzschig, H.K., Sitkovsky, M.V. & Robson, S.C. Purinergic signaling during inflammation. N. Engl. J. Med. 367, 2322-2333 (2012
29. Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232 (2006
30. Gris, D. et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J. Immunol. 185, 974-981 (2010
31. Martinon, F., Mayor, A. & Tschopp, J. The inflammasomes: Guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009
32. Tacken, P.J., de Vries, I.J., Torensma, R. & Figdor, C.G. Dendritic-cell immunotherapy: From ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7, 790-802 (2007
33. Dhodapkar, M.V., Steinman, R.M., Krasovsky, J., Munz, C. & Bhardwaj, N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233-238 (2001
34. Quintana, F.J. et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc. Natl. Acad. Sci. USA 105, 18889-18894 (2008
35. Robinson, W.H. et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat. Biotechnol. 21, 1033-1039 (2003
36. Apetoh, L. et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854-861 (2010
37. Moore, K.W., de Waal Malefyt, R., Coffman, R.L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765 (2001
38. Melillo, J.A. et al. Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function. J. Immunol. 184, 2638-2645 (2010
39. Baker, B.J., Park, K.W., Qin, H., Ma, X. & Benveniste, E.N. IL-27 inhibits OSM-mediated TNF-α and iNOS gene expression in microglia. Glia 58, 1082-1093 (2010
40. Färber, K. et al. The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Glia 56, 331-341 (2008
41. Mizumoto, N. et al. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: Modulatory roles in inflammation and immune responsiveness. Nat. Med. 8, 358-365 (2002
42. Sutterwala, F.S. et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24, 317-327 (2006
43. Eisenbarth, S.C., Colegio, O.R., O'Connor, W., Sutterwala, F.S. & Flavell, R.A. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453, 1122-1126 (2008
44. Meng, G., Zhang, F., Fuss, I., Kitani, A. & Strober, W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 30, 860-874 (2009
45. Jähnisch, H. et al. Dendritic cell-based immunotherapy for prostate cancer. Clin. Dev. Immunol. 2010, 517493 (2010
46. Yeste, A., Nadeau, M., Burns, E.J., Weiner, H.L. & Quintana, F.J. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 109, 11270-11275 (2012
47. Starossom, S.C. et al. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 37, 249-263 (2012
48. Quintana, F.J. et al. Aiolos promotes TH17 differentiation by directly silencing Il2 expression. Nat. Immunol. 13, 770-777 (2012
49. Quintana, F.J. et al. Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65-71 (2008
50. Sun, X. et al. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 139, 1030-1040 (2010